Literature DB >> 33358110

Exercise Benefits Meet Cancer Immunosurveillance: Implications for Immunotherapy.

Carmen Fiuza-Luces1, Pedro L Valenzuela2, Adrián Castillo-García3, Alejandro Lucia4.   

Abstract

Regular exercise reduces the risk of cancer. One potential mechanism for this efficacy is improved antitumor immunity. This is an important issue because evading immune destruction is a hallmark of cancer and immunotherapy is reshaping cancer treatment. Here we review recent developments reported by Wennerberg et al., Garritson et al., Martín-Ruiz et al., and Rundqvist et al. on the effects of exercise on anticancer immune cell effectors.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD8+ cells; NK cells; lymphocytes; physical activity

Year:  2021        PMID： 33358110     DOI： 10.1016/j.trecan.2020.12.003

Source DB:  PubMed          Journal:  Trends Cancer        ISSN： 2405-8025


  3 in total

Review 1.  Therapeutic approach for digestive system cancers and potential implications of exercise under hypoxia condition: what little is known? a narrative review.

Authors:  Sergio Pérez Regalado; Josefa León; Belén Feriche
Journal:  J Cancer Res Clin Oncol       Date:  2022-02-14       Impact factor: 4.322

2.  Effects of Exercise Interventions on Immune Function in Children and Adolescents With Cancer and HSCT Recipients - A Systematic Review.

Authors:  Ronja Beller; Sabrina Bianca Bennstein; Miriam Götte
Journal:  Front Immunol       Date:  2021-09-27       Impact factor: 7.561

Review 3.  Cancer Cell Metabolism Reprogramming and Its Potential Implications on Therapy in Squamous Cell Carcinoma of the Head and Neck: A Review.

Authors:  Francesco Perri; Giuseppina Della Vittoria Scarpati; Monica Pontone; Maria Luisa Marciano; Alessandro Ottaiano; Marco Cascella; Francesco Sabbatino; Agostino Guida; Mariachiara Santorsola; Piera Maiolino; Ernesta Cavalcanti; Giulia Togo; Franco Ionna; Francesco Caponigro
Journal:  Cancers (Basel)       Date:  2022-07-22       Impact factor: 6.575
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.